Machine learning and metabolomics identify biomarkers associated with the disease extent of ulcerative colitis.
Journal:
Journal of Crohn's & colitis
PMID:
39903649
Abstract
BACKGROUND AND AIMS: Ulcerative colitis (UC) is a metabolism-related chronic intestinal inflammatory disease. Disease extent is a key parameter of UC. Using serum metabolic profiling to identify noninvasive biomarkers of disease extent may inform therapeutic decisions and risk stratification.